Online ISSN 2313-1519
Print    ISSN 1812-2892
Abstract - Stem cells therapy in inflammatory bowel disease
[PDF]            [Full text/HTML]           
Venera Rakhmetova, Aida Orazbayeva

ABSTRACT

The article analyzes the experience of applying various stem cell pools in the treatment of inflammatory diseases of the colon. Basic and clinical studies on properties of mesenchymal stem cells and clinical effects of various technologies for their use conducted held in recent years allows to consider the mesenchymal stem cells transplantation as a new and promising direction in the treatment of ulcerative colitis.

Key words: Inflammatory bowel disease, mesenchymal stem cell, transplantation, regenerative medicine.

REFERENCES

1. Khalif I.L., Loranskaya I.D., Vospalitel'nye zabolevaniya kishechnika (nespetsificheskii yazvennyi koliti, bolezn' Krona): klinika, diagnostika, lechenie (Inflammatory bowel disease (ulcerative colitis and Crohn's disease): clinic, diagnosis, treatment) [inRussian]. M: Miklosh. 2004;pp. 88.

2. Adler G. Bolezn' Krona I yazvennyi kolit (Crohn's disease and ulcerative colitis) [in Russian].M: GEOTAR-MED. 2001;pp. 527.

3. Vorob'ev G.I., Khalif I.L. Nespetsificheskie vospalitel'nye zabolevaniya kishechnika (Nonspecific inflammatory bowel disease) [in Russian]. M: Miklosh. 2008; pp 400.

4. Belousova E.A. Yazvennyi kolit i bolezn' Krona (Ulcerative colitis and Crohn's disease) [in Russian]. Tver': Izdatel'stvo «Triada».2002; pp128.

5. Gomollón F, Dignass A, Annese V, Tilg H, Van Assche G, Lindsay JO, Peyrin-Biroulet L, Cullen GJ, Daperno M, Kucharzik T, Rieder F. 3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: part 1: diagnosis and medical management. Journal of Crohn's and Colitis. 2016;11(1):3-25.
https://doi.org/10.1093/ecco-jcc/jjw168

6. Harbord M, Eliakim R, Bettenworth D, Karmiris K, Katsanos K, Kopylov U, Kucharzik T, Molnár T, Raine T, Sebastian S, de Sousa HT. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management. Journal of Crohn's and Colitis. 2017; 1–24.
https://doi.org/10.1093/ecco-jcc/jjx009

7. Mowat C, Cole A, Windsor A, Ahmad T, Arnott I, Driscoll R, Mitton S, Orchard T, Rutter M, Younge L, Lees C. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2011;60(5):571-607.
https://doi.org/10.1136/gut.2010.224154

8. Peyrin-Biroulet L, Bouhnik Y, Roblin X, Bonnaud G, Hagège H, Hébuterne X. French national consensus clinical guidelines for the management of ulcerative colitis. Digestive and Liver Disease. 2016;48(7):726-33.
https://doi.org/10.1016/j.dld.2016.03.029

9. Satsangi J. Morecroft N.B. Genetics of inflammatory bowel disease: scientific and clinical implications. Best Pract. Res. Clin. Gastroenterology.2003;17:3-18.
https://doi.org/10.1053/bega.2002.0349

10. Yamamoto-Furusho JK, Podolsky DK. Innate immunity in inflammatory bowel disease. World journal of gastroenterology. 2007;13(42):5577.
https://doi.org/10.3748/wjg.v13.i42.5577

11. Farell R., Pepperkorn M. Yazvennyikolit (Ulcerative colitis) [in Russian], Mezhdunarodnyi meditsinskii zhurnal.2003;1(6): http://medi.ru/doc/773012.htm.

12. Munkholm P, Langholz E, Davidsen M, Binder V. Frequency of glucocorticoid resistance and dependency in Crohn9s disease. Gut. 1994 Mar 1;35(3):360-2.
https://doi.org/10.1136/gut.35.3.360

13. Faubion WA, Loftus EV, Harmsen WS, Zinsmeister AR, Sandborn WJ. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology. 2001;121(2):255-60.
https://doi.org/10.1053/gast.2001.26279

14. Kalinina N. I., Sysoeva V. Yu., Rubina K. A., Parfenova E. V., Tkachuk V.A. Annotatsiya nauchnoi stat'i «Mezenkhimal'nye stvolovye kletki v protsessa khrostaireparatsi i tkanei» (Mesenchymal stem cells in tissue growth and repair processes) [in Russian]. Acta Naturae. 2011;3(4).

15. Ditschkowski M, Einsele H, Schwerdtfeger R, Bunjes D, Trenschel R, Beelen DW, Elmaagacli AH. Improvement of inflammatory bowel disease after allogeneic stem-cell transplantation. Transplantation. 2003 May 27;75(10):1745-7.
https://doi.org/10.1097/01.TP.0000062540.29757.E9

16. Oyama Y, Craig RM, Traynor AE, Quigley K, Statkute L, Halverson A, Brush M, Verda L, Kowalska B, Krosnjar N, Kletzel M. Autologous hematopoietic stem cell transplantation in patients with refractory Crohn's disease. Gastroenterology. 2005;128(3):552-63.
https://doi.org/10.1053/j.gastro.2004.11.051

17. Cassinotti A, Annaloro C, Ardizzone S, Onida F, Della Volpe A, Clerici M, Usardi P, Greco S, Maconi G, Porro GB, Deliliers GL. Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease. Gut. 2008;57(2):211-7.
https://doi.org/10.1136/gut.2007.128694

18. Dryden G.W. Overview of stem cell therapy for Crohn disease. Expert. Opin. Biol. Ther. 2009;9:841–847.
https://doi.org/10.1517/14712590902956615
https://doi.org/10.1517/14712590903048909

19. Burt R.K., Traynor A., Oyama Y., Craig R. High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn disease. Blood. 2003;101:2064–2066.
https://doi.org/10.1182/blood-2002-07-2122

20. Nasadyuk CM. Stem Cell Therapy In The Treatment Of Inflammatory Bowel Disease. Gastroenterology&Hepatology: Open Access. 2014;1(1):00006.

21. I.V. Mayanskaya, A.Yu. Goganova, N.I. Tolkachova, V.I. Achkinazi, A.N. Mayansky. Immunosuppressive activity of mesenchymal stem (stromal) cells [In Russian]. Immunology. 2013;34(2):122-128

22. Hawkey C. J. Stem cell transplantation for Crohn's disease. Best Pract Res Clin. Haematol.2004;17(2):317-325.
https://doi.org/10.1016/j.beha.2004.05.006

23. Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W, Ljungman P, Ferrant A, Verdonck L, Niederwieser D. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood. 1995;86(5):2041-50.

24. McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, Clarke-Pearson DL, Davidson M. Cyclopho-sphamkte and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N. Engl. J. Med. 1996;334(1):1-6.
https://doi.org/10.1056/NEJM199601043340101

25. Nasonov E. L. Sovremennye napravleniya immunologicheskikh issledovanii pri khronicheskikh vospalitel'nykh i autoimmunnykh zabolevaniyakh cheloveka (Modern trends of immunological studies in chronic inflammatory and autoimmune diseases of man) [in Russian]. Ter. arkhiv. 2001;73(8):43— 46.

26. Nazarenko G. I., Kishkun A. A. Klinicheskaya otsenka rezul'tatov laboratornykh issledovanii (Clinical evaluation of laboratory results) [in Russian]. M.: Meditsina. 2002; pp 544.

27. Shevchenko Yu. L., Boitsov S. A., Novik A. A., Lyadov K. V. Kontseptsiya kletochnoi terapii autoimmunnykh zabolevanii (The concept of cell therapy of autoimmune diseases) [in Russian]. Vestn.Ros. AMN.2004;9:40-4.

28. Singh UP, Singh NP, Singh B, Mishra MK, Nagarkatti M, Nagarkatti PS, Singh SR. Stem cells as potential therapeutic targets for inflammatory bowel disease. Frontiers in bioscience (Scholar edition). 2010;1:993–1008.
https://doi.org/10.2741/s115

29. Lazebnik L.B., Knyazev O.V., Konoplyannikov A.G. i dr. Allogennye mezenkhimal'nye stromal'nye kletki v lechenii bol'nykh yazvennym kolitom: dva goda nablyudeniya (Allogenic mesenchymal stromal cells in the treatment of patients with ulcerative colitis: two years of follow-up) [in Russian]. Klin.eksperiment. gastroenterol.2010;11:3–15.

 

Volume 4, Number 46 (2017)